Clinical Trial Update: A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects. [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetics study evaluates albiglutide in individuals with normal renal function and those with renal impairment to understand how kidney fun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Albiglutide (albiglutide)
• Tanzeum (Albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED